These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 411945)

  • 1. Retention and tissue distribution of 210Pb (NO3)2 administered orally to infant and adult monkeys.
    Willes RF; Lok E; Truelove JF; Sundaram A
    J Toxicol Environ Health; 1977 Oct; 3(3):395-406. PubMed ID: 411945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and blood lead concentrations, lead absorption, and lead excretion in nonhuman primates.
    O'Flaherty EJ; Inskip MJ; Yagminas AP; Franklin CA
    Toxicol Appl Pharmacol; 1996 May; 138(1):121-30. PubMed ID: 8658501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution of lead in the neonatal rat exposed to multiple doses of lead acetate.
    Miller GD; Massaro TF; Granlund RW; Massaro EJ
    J Toxicol Environ Health; 1983 Jan; 11(1):121-8. PubMed ID: 6827619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple dose exposure effects on the tissue distribution of lead in the preweanling rat.
    Massaro EJ; Miller GD; Massaro TF
    Neurotoxicology; 1984; 5(3):333-51. PubMed ID: 6542980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.
    Kitagawa H; Esumi Y; Kurosawa S; Sekine S; Yokoshima T
    Xenobiotica; 1979 Jul; 9(7):415-28. PubMed ID: 40350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dose level and pregnancy on the distribution and toxicity of intravenous lead in rats.
    Hackett PL; Hess JO; Sikov MR
    J Toxicol Environ Health; 1982; 9(5-6):1007-20. PubMed ID: 7120503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Succimer and the reduction of tissue lead in juvenile monkeys.
    Smith DR; Woolard D; Luck ML; Laughlin NK
    Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and modification of a physiologically based model of lead kinetics using data from a sequential isotope study in cynomolgus monkeys.
    O'Flaherty EJ; Inskip MJ; Franklin CA; Durbin PW; Manton WI; Baccanale CL
    Toxicol Appl Pharmacol; 1998 Mar; 149(1):1-16. PubMed ID: 9512721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schedule-controlled behavior in infant and juvenile monkeys exposed to lead from birth.
    Rice DC
    Neurotoxicology; 1988; 9(1):75-87. PubMed ID: 3393304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of lead (Pb) in saliva and blood of Sprague-Dawley rats following a single or repeated oral exposure to Pb-acetate.
    Timchalk C; Lin Y; Weitz KK; Wu H; Gies RA; Moore DA; Yantasee W
    Toxicology; 2006 May; 222(1-2):86-94. PubMed ID: 16510233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective tissue distribution of tibolone metabolites in mature ovariectomized female cynomolgus monkeys after multiple doses of tibolone.
    Verheul HA; van Iersel ML; Delbressine LP; Kloosterboer HJ
    Drug Metab Dispos; 2007 Jul; 35(7):1105-11. PubMed ID: 17420283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of CaNa(2)EDTA on brain lead mobilization in rodents determined using a stable lead isotope tracer.
    Seaton CL; Lasman J; Smith DR
    Toxicol Appl Pharmacol; 1999 Sep; 159(3):153-60. PubMed ID: 10486301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of caffeine in premature infants and in newborn and adult dogs.
    Warszawski D; Gorodischer R
    Pediatr Pharmacol (New York); 1981; 1(4):341-6. PubMed ID: 7202186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.